These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 35762211)

  • 1.
    Jimenez-Vazquez EN; Arad M; Macías Á; Vera-Pedrosa ML; Cruz FM; Gutierrez LK; Cuttitta AJ; Monteiro da Rocha A; Herron TJ; Ponce-Balbuena D; Guerrero-Serna G; Binah O; Michele DE; Jalife J
    Elife; 2022 Jun; 11():. PubMed ID: 35762211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiological abnormalities in induced pluripotent stem cell-derived cardiomyocytes generated from Duchenne muscular dystrophy patients.
    Eisen B; Ben Jehuda R; Cuttitta AJ; Mekies LN; Shemer Y; Baskin P; Reiter I; Willi L; Freimark D; Gherghiceanu M; Monserrat L; Scherr M; Hilfiker-Kleiner D; Arad M; Michele DE; Binah O
    J Cell Mol Med; 2019 Mar; 23(3):2125-2135. PubMed ID: 30618214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brugada syndrome trafficking-defective Nav1.5 channels can trap cardiac Kir2.1/2.2 channels.
    Pérez-Hernández M; Matamoros M; Alfayate S; Nieto-Marín P; Utrilla RG; Tinaquero D; de Andrés R; Crespo T; Ponce-Balbuena D; Willis BC; Jiménez-Vazquez EN; Guerrero-Serna G; da Rocha AM; Campbell K; Herron TJ; Díez-Guerra FJ; Tamargo J; Jalife J; Caballero R; Delpón E
    JCI Insight; 2018 Sep; 3(18):. PubMed ID: 30232268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kir2.1-Na
    Gutiérrez LK; Moreno-Manuel AI; Jalife J
    Heart Rhythm; 2024 May; 21(5):630-646. PubMed ID: 38244712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling Duchenne Muscular Dystrophy Cardiomyopathy with Patients' Induced Pluripotent Stem-Cell-Derived Cardiomyocytes.
    Eisen B; Binah O
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of full-length dystrophin impairs normal maturation and contraction of cardiomyocytes derived from human-induced pluripotent stem cells.
    Pioner JM; Guan X; Klaiman JM; Racca AW; Pabon L; Muskheli V; Macadangdang J; Ferrantini C; Hoopmann MR; Moritz RL; Kim DH; Tesi C; Poggesi C; Murry CE; Childers MK; Mack DL; Regnier M
    Cardiovasc Res; 2020 Feb; 116(2):368-382. PubMed ID: 31049579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreasing microtubule detyrosination modulates Nav1.5 subcellular distribution and restores sodium current in mdx cardiomyocytes.
    Nasilli G; de Waal TM; Marchal GA; Bertoli G; Veldkamp MW; Rothenberg E; Casini S; Remme CA
    Cardiovasc Res; 2024 May; 120(7):723-734. PubMed ID: 38395031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac Kir2.1 and Na
    Ponce-Balbuena D; Guerrero-Serna G; Valdivia CR; Caballero R; Diez-Guerra FJ; Jiménez-Vázquez EN; Ramírez RJ; Monteiro da Rocha A; Herron TJ; Campbell KF; Willis BC; Alvarado FJ; Zarzoso M; Kaur K; Pérez-Hernández M; Matamoros M; Valdivia HH; Delpón E; Jalife J
    Circ Res; 2018 May; 122(11):1501-1516. PubMed ID: 29514831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioenergetic and Metabolic Impairments in Induced Pluripotent Stem Cell-Derived Cardiomyocytes Generated from Duchenne Muscular Dystrophy Patients.
    Willi L; Abramovich I; Fernandez-Garcia J; Agranovich B; Shulman M; Milman H; Baskin P; Eisen B; Michele DE; Arad M; Binah O; Gottlieb E
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein assemblies of sodium and inward rectifier potassium channels control cardiac excitability and arrhythmogenesis.
    Willis BC; Ponce-Balbuena D; Jalife J
    Am J Physiol Heart Circ Physiol; 2015 Jun; 308(12):H1463-73. PubMed ID: 25862830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nav1.5 N-terminal domain binding to α1-syntrophin increases membrane density of human Kir2.1, Kir2.2 and Nav1.5 channels.
    Matamoros M; Pérez-Hernández M; Guerrero-Serna G; Amorós I; Barana A; Núñez M; Ponce-Balbuena D; Sacristán S; Gómez R; Tamargo J; Caballero R; Jalife J; Delpón E
    Cardiovasc Res; 2016 May; 110(2):279-90. PubMed ID: 26786162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syncytium cell growth increases Kir2.1 contribution in human iPSC-cardiomyocytes.
    Li W; Han JL; Entcheva E
    Am J Physiol Heart Circ Physiol; 2020 Nov; 319(5):H1112-H1122. PubMed ID: 32986966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling and study of the mechanism of dilated cardiomyopathy using induced pluripotent stem cells derived from individuals with Duchenne muscular dystrophy.
    Lin B; Li Y; Han L; Kaplan AD; Ao Y; Kalra S; Bett GC; Rasmusson RL; Denning C; Yang L
    Dis Model Mech; 2015 May; 8(5):457-66. PubMed ID: 25791035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced Na
    Ebner J; Uhrin P; Szabo PL; Kiss A; Podesser BK; Todt H; Hilber K; Koenig X
    Am J Physiol Heart Circ Physiol; 2020 Jun; 318(6):H1436-H1440. PubMed ID: 32383994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Kir2.1E299V mutation increases atrial fibrillation vulnerability while protecting the ventricles against arrhythmias in a mouse model of short QT syndrome type 3.
    Moreno-Manuel AI; Macías Á; Cruz FM; Gutiérrez LK; Martínez F; González-Guerra A; Martínez Carrascoso I; Bermúdez-Jimenez FJ; Sánchez-Pérez P; Vera-Pedrosa ML; Ruiz-Robles JM; Bernal JA; Jalife J
    Cardiovasc Res; 2024 Apr; 120(5):490-505. PubMed ID: 38261726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Empagliflozin treatment rescues abnormally reduced Na
    Sauer J; Marksteiner J; Lilliu E; Hackl B; Todt H; Kubista H; Dostal C; Podesser BK; Kiss A; Koenig X; Hilber K
    Am J Physiol Heart Circ Physiol; 2024 Feb; 326(2):H418-H425. PubMed ID: 38099845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depressed β-adrenergic inotropic responsiveness and intracellular calcium handling abnormalities in Duchenne Muscular Dystrophy patients' induced pluripotent stem cell-derived cardiomyocytes.
    Mekies LN; Regev D; Eisen B; Fernandez-Gracia J; Baskin P; Ben Jehuda R; Shulman R; Reiter I; Palty R; Arad M; Gottlieb E; Binah O
    J Cell Mol Med; 2021 Apr; 25(8):3922-3934. PubMed ID: 33619882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-Specific and Gene-Corrected Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Short QT Syndrome.
    Guo F; Sun Y; Wang X; Wang H; Wang J; Gong T; Chen X; Zhang P; Su L; Fu G; Su J; Yang S; Lai R; Jiang C; Liang P
    Circ Res; 2019 Jan; 124(1):66-78. PubMed ID: 30582453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRF2 rescues telomere attrition and prolongs cell survival in Duchenne muscular dystrophy cardiomyocytes derived from human iPSCs.
    Eguchi A; Gonzalez AFGS; Torres-Bigio SI; Koleckar K; Birnbaum F; Zhang JZ; Wang VY; Wu JC; Artandi SE; Blau HM
    Proc Natl Acad Sci U S A; 2023 Feb; 120(6):e2209967120. PubMed ID: 36719921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiological mechanisms of vandetanib-induced cardiotoxicity: Comparison of action potentials in rabbit Purkinje fibers and pluripotent stem cell-derived cardiomyocytes.
    Lee HA; Hyun SA; Byun B; Chae JH; Kim KS
    PLoS One; 2018; 13(4):e0195577. PubMed ID: 29630634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.